The application value of serological detection of ASCA and ANCA serum level in the diagnosis and treatment of inflammatory bowel disease / 中华检验医学杂志
Chinese Journal of Laboratory Medicine
; (12): 708-711, 2018.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-712199
Responsible library:
WPRO
ABSTRACT
With the updating of the consensus on the diagnosis and treatment of inflammatory bowel disease, ASCA, ANCA and other serological markers are not included as routine examination items , so many related problems need to be recognized .In some special cases , the high specific serological examination still has clinical value in the differential diagnosis for atypical symptom patents .Researches support that ASCA , ANCA and other serological tests have the ability to predict the occurrence of the disease , to evaluate the biological behavior , or to predict clinical response to infliximab and the recurrence after surgery .Finding new methods for combined detection to increase sensitivity and specificity , discovery of new serological antibodies are still research hotspots in the future ."no agreement have been reached about serological detection" in the new consensus is just the expectation of large-scale, multicenter clinical research on serological detection of IBD in China .
Full text:
Available
Database:
WPRIM (Western Pacific)
Type of study:
Diagnostic study
/
Prognostic study
Aspects:
Patient-preference
Language:
Chinese
Journal:
Chinese Journal of Laboratory Medicine
Year:
2018
Document type:
Article